Indian Pharma Resilient as US Weighs 25% Tariffs on Imports

On February 19, pharmaceutical stocks faced pressure after remarks from US President Donald Trump, indicating that the US could implement tariffs close to 25% on imports of pharmaceuticals, automobiles, and semiconductors...

Pharma Firms Directed to Update MRP by NPPA post Budget 2025 Duty Exemptions

The maximum retail price (MRP) of medications and formulations that are no longer subject to customs duty has been adjusted by the National Pharmaceutical Pricing Authority (NPPA) in accordance with this year's budget.

Pharmaceutical Bodies Recommend Concessions on Medical Exports

In the context of ongoing US-India discussions on tariffs, key pharmaceutical industry bodies in India—Pharmaceuticals Exports Promotion Council (Pharmexcil), Indian Pharmaceutical Association (IPA), and Indian Drug Manufacturers Association (IDMA...

Government Extends Deadline for MSMEs to Implement Schedule M Standards

The government has granted a one-year extension to small and medium-sized pharmaceutical companies (with annual turnover below Rs 250 crore) to meet the revised Schedule M standards, which set quality standards and good manufacturing practices (GM...

C2 PHARMA Secures EDQM CEP Approval for Oxybuprocaine Hydrochloride

C2 PHARMA has disclosed the approval of a Certificate of Suitability (CEP) for Oxybuprocaine Hydrochloride from the European Directorate for the Quality of Medicines and Health Care (EDQM). Oxybuprocaine Hydrochloride is presently accessible to...

EU Recommends Approval of Dato-DXd for Advanced HR+ HER2- Breast Cancer

Datopotamab deruxtecan (Dato-DXd) has received a recommendation for approval in the European Union (EU) to treat adult patients with unresectable or metastatic hormone receptor (HR) positive, HER2 negative (IHC 0, IHC 1+ or IHC 2+/ISH-) breast...

EMA Panel Approves Bavarian Nordic's Vimkunya for Chikungunya Prevention

Bavarian Nordic A/S, a worldwide vaccine firm dedicated to enhancing health and saving lives via innovative vaccines, revealed that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a...

March Bioscience's MB-105 CAR-T Therapy Earns FDA Orphan Drug Status

Houston-based March Biosciences, an emerging clinical stage biotechnology company committed to combating challenging cancers and other diseases, announced that the US Food and Drug Administration (FDA) granted orphan drug designation to MB-105...

Granules Pharmaceuticals Secures USFDA Nod for Key Generic Drug

Granules India Limited, an integrated Indian pharma firm, declared that its wholly-owned foreign subsidiary, Granules Pharmaceuticals, Inc. (GPI), has obtained final approval from the U.S. Food & Drug Administration (USFDA) for its Abbreviated New...

NATCO Pharma Receives FDA Approval for Generic Everolimus Tablets

NATCO Pharma announced that it has obtained approval for its ANDA concerning Everolimus tablets for oral suspension (TFOS), a generic equivalent of AFINITOR DISPERZ from Novartis Pharmaceutical Corporation. Breckenridge Pharmaceutical, Inc, the...

© 2025 India Pharma Outlook. All Rights Reserved.

Safety Monitoring